Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A functional loop between YTH domain family protein YTHDF3 mediated m6A modification and phosphofructokinase PFKL in glycolysis of hepatocellular carcinoma
Rong Zhou, Wen Ni, Chao Qin, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

m6A-regulated tumor glycolysis: new advances in epigenetics and metabolism
Shiwei Yue, Hailing Liu, Hong-Fei Su, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 47
RNA modifications in cellular metabolism: implications for metabolism-targeted therapy and immunotherapy
Weiwei Liu, Si-Qing Zheng, Li Tian, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 36
The emerging importance role of m6A modification in liver disease
Sheng Wang, Songsen Gao, Wufei Ye, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114669-114669
Open Access | Times Cited: 30
Critical roles and clinical perspectives of RNA methylation in cancer
Ganglei Li, Qinfan Yao, Peixi Liu, et al.
MedComm (2024) Vol. 5, Iss. 5
Open Access | Times Cited: 17
Cellular senescence and metabolic reprogramming: Unraveling the intricate crosstalk in the immunosuppressive tumor microenvironment
Fusheng Zhang, Junchen Guo, Shengmiao Yu, et al.
Cancer Communications (2024) Vol. 44, Iss. 9, pp. 929-966
Open Access | Times Cited: 16
RNA modification-mediated mRNA translation regulation in liver cancer: mechanisms and clinical perspectives
Shuibin Lin, Ming Kuang
Nature Reviews Gastroenterology & Hepatology (2024) Vol. 21, Iss. 4, pp. 267-281
Closed Access | Times Cited: 10
A novel MYCN-YTHDF1 cascade contributes to retinoblastoma tumor growth by eliciting m6A -dependent activation of multiple oncogenes
Yingxiu Luo, Mengjia He, Jie Yang, et al.
Science China Life Sciences (2023) Vol. 66, Iss. 9, pp. 2138-2151
Open Access | Times Cited: 16
RNA modifications in the progression of liver diseases: from fatty liver to cancer
Simiao Li‐Sauerwine, Wajahat Z. Mehal, Xinshou Ouyang
Science China Life Sciences (2024) Vol. 67, Iss. 10, pp. 2105-2119
Open Access | Times Cited: 6
Targeting RNA modifications with pharmacological agents: New frontiers in cancer therapy
Angel Guan, Justin Wong
Cancer Medicine (2024) Vol. 13, Iss. 7
Open Access | Times Cited: 4
The biological function of the N6-Methyladenosine reader YTHDC2 and its role in diseases
Xudong Wu, Hui Chen, Kai Li, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
The YTH domain‐containing protein family: Emerging players in immunomodulation and tumour immunotherapy targets
Fenghe Li, Chong Zeng, Jie Liu, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 8
Open Access | Times Cited: 4
Changes in m6A in Steatotic Liver Disease
Belinda J. Petri, Matthew C. Cave, Carolyn M. Klinge
Genes (2023) Vol. 14, Iss. 8, pp. 1653-1653
Open Access | Times Cited: 10
Emerging importance of m6A modification in liver cancer and its potential therapeutic role
Tao Chen, Wufei Ye, Songsen Gao, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189299-189299
Closed Access
M6A-modified BFSP1 induces aerobic glycolysis to promote liver cancer growth and metastasis through upregulating tropomodulin 4
Rong Li, Shunle Li, Lin Shen, et al.
Molecular Biomedicine (2025) Vol. 6, Iss. 1
Open Access
Single-cell sequencing and spatial transcriptomics reveal the evolution of glucose metabolism in hepatocellular carcinoma and identify G6PD as a potential therapeutic target
Deyang Xi, Yinshuang Yang, Jiayi Guo, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Transcriptomic analysis reveals the function of m6A regulators in aged cochlea
Yanbing Lai, Bo Su, Xiaodi Wang, et al.
Brazilian Journal of Otorhinolaryngology (2025) Vol. 91, Iss. 3, pp. 101578-101578
Closed Access
Summary of the mechanism of ferroptosis regulated by m6A modification in cancer progression
Bin Fan, Gangxian Chen, Shu‐Yi Huang, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
The m6A reader YTHDF3 promotes TNBC progression by regulating CENPI stabilization
Yulu Zhang, Shunji Chen, Qiaosheng Wu
Frontiers in Oncology (2025) Vol. 15
Open Access
Targeting m6A binding protein YTHDFs for cancer therapy
Weikun Zhang, Tingting Wu, Yue‐Jiao Zhang, et al.
Bioorganic & Medicinal Chemistry (2023) Vol. 90, pp. 117373-117373
Closed Access | Times Cited: 9
Cancer metastasis under the magnifying glass of epigenetics and epitranscriptomics
Maxime Janin, Verónica Dávalos, Manel Esteller
Cancer and Metastasis Reviews (2023) Vol. 42, Iss. 4, pp. 1071-1112
Open Access | Times Cited: 9
The feedback loop of EFTUD2/c-MYC impedes chemotherapeutic efficacy by enhancing EFTUD2 transcription and stabilizing c-MYC protein in colorectal cancer
Xiaojian Zhu, Changxue Li, Yunfei Gao, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 3
N6-methyladenosine (m6A) modification in hepatocellular carcinoma
Hehua Ma, Yuxin Hong, Zhenzhen Xu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116365-116365
Open Access | Times Cited: 3
Emerging function of main RNA methylation modifications in the immune microenvironment of digestive system tumors
Yifan Zeng, Tao Yu, Zhuoqi Lou, et al.
Pathology - Research and Practice (2024) Vol. 256, pp. 155268-155268
Open Access | Times Cited: 3
EIF4A3‐Induced CircDHTKD1 regulates glycolysis in non‐small cell lung cancer via stabilizing PFKL
Zhenghua Liu, Wenya Li, Ziyi Wang, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 14
Open Access | Times Cited: 3
EFTUD2 is a promising diagnostic and prognostic indicator involved in the tumor immune microenvironment and glycolysis of lung adenocarcinoma
Ankang Yin, Yufan Xu, Xiyang Su, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Page 1 - Next Page

Scroll to top